TrialThe Journal of infectious diseases2012

Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).

Ann Duerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.